Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,485 | -11,525 | -42,015 | -31,416 | -21,421 |
| Depreciation Amortization | 59 | 29 | 258 | 228 | 156 |
| Accounts payable and accrued liabilities | -212 | -597 | -1,217 | -2,093 | -2,035 |
| Other Working Capital | -562 | -2,653 | -342 | -1,895 | -1,472 |
| Other Operating Activity | 3,323 | 2,137 | 7,153 | 6,621 | 5,090 |
| Operating Cash Flow | $-20,877 | $-12,609 | $-36,163 | $-28,555 | $-19,682 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | N/A | -92 | -92 | -87 |
| Investing Cash Flow | $-30 | $N/A | $-92 | $-92 | $-87 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 46,129 | 46,097 | 27,588 | 27,445 | 27,445 |
| Financing Cash Flow | $46,129 | $46,097 | $27,588 | $27,445 | $27,445 |
| Exchange Rate Effect | -33 | -20 | -4 | 6 | 3 |
| Beginning Cash Position | 100,536 | 100,536 | 109,207 | 109,207 | 109,207 |
| End Cash Position | 125,725 | 134,004 | 100,536 | 108,011 | 116,886 |
| Net Cash Flow | $25,189 | $33,468 | $-8,671 | $-1,196 | $7,679 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,877 | -12,609 | -36,163 | -28,555 | -19,682 |
| Capital Expenditure | -30 | N/A | -92 | -92 | -87 |
| Free Cash Flow | -20,907 | -12,609 | -36,255 | -28,647 | -19,769 |